SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4711 US Bioscience Reports 'Encouraging' Data On Lodenosine July 2 Dow JoSteve Fancy-7/2/1998
4710 Study: Immune Response and Agouron Drug Helps HIV Patients July 2, 1998 DoSteve Fancy-7/2/1998
4709 Enzo Biochem HGTV43 Shows 'High' Protection Level Vs HIV Dow Jones NeSteve Fancy-7/2/1998
4708 AIDS Prevention Vaccine May Instead Cause The Disease Dow Jones Newswires GSteve Fancy-7/2/1998
4707 <<Gallo recently was quoted, saying that there has been a bit of luck obmargie-7/2/1998
4706 I guess I am missing something but I haven't been able to see anything &quomargie-7/2/1998
4705 <b>PaineWebber Morning Notes July 2, 1988 Agouron: PreliSteve Fancy-7/2/1998
4704 I have read Elise's note and it is well reasoned. I think her 2000 estimatVector1-7/2/1998
4703 AGPH stock price drop is certainly coming as a shock to me as I obviously expecIzzy-7/2/1998
4702 That maybe, but her comments *never* move the stock, and her 12 month price Steve Fancy-7/2/1998
4701 Regarding Paine Webber biotech analyst Elsie Wang, I see in the June 30th Wall Zirdu-7/2/1998
4700 Well, I'm the fool, this Remune data was released yesterday...apparentlySteve Fancy-7/2/1998
4699 Interesting data. Sounds decent, about what I was expecting. Again, I don'scaram(o)uche-7/2/1998
4698 Re: Remune press release These are very good results. Generating an immune resJoe E.-7/2/1998
4697 >> At the dose studied in uninfected volunteers, the combination of scaram(o)uche-7/2/1998
4696 Encouraging Preliminary Clinical Results Reported for Immune-Based Therapy REMUkfdkfd-7/2/1998
4695 100 Percent of Patients Showed Suppressed HIV Replication in Cerebrospinal Flukfdkfd-7/2/1998
4694 Bill, thanks. You are very much a true gentleman. Like Peter has said, the YahoIzzy-7/2/1998
4693 Izzy: Yes. These prices are a great value. That said, the buying opportunity billkirn-7/2/1998
4692 Speaking of analysts Mike King of Vector Securities posted an excellent note onVector1-7/2/1998
4691 nothing we didn't already know..... ama-assn.orgscaram(o)uche-7/2/1998
4690 Bill, do you plan to update your web site and possibly add a commentary on IMNRIzzy-7/1/1998
4689 Steve: Bought some IMNR after AGPH entry. Don't expect the results to be billkirn-7/1/1998
4688 Well, the folks on the IMNR thread seem to be holding high hopes. Hope it&#Steve Fancy-7/1/1998
4687 Thanks Rick, kind of obvious suggestion, but never thought to look over therSteve Fancy-7/1/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News